Evidence map›Paper›PMID 39257341›Full record

ArticleArthritis care & research2025

Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.

Gregory C McDermott, Keigo Hayashi, Pierre-Antoine Juge, Ritu Gill, Suzanne Byrne, Staci Gagne, Xiaosong Wang, Misti L Paudel, Matthew Moll, Michael H Cho and 14 more

Abstract read
In one paragraph

Article in Arthritis care & research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Gregory C McDermottBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-9750-5448
Keigo HayashiBrigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0002-2935-6284
Pierre-Antoine JugeBrigham and Women's Hospital, Boston, Massachusetts, Université de Paris Cité, INSERM UMR 1152 and Hôpital Bichat-Claude Bernard, AP-HP, Paris, France.ORCID 0000-0002-3766-9600
Ritu GillHarvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Suzanne ByrneBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Staci GagneBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Xiaosong WangBrigham and Women's Hospital, Boston, Massachusetts.
Misti L PaudelBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-8361-0650
Matthew MollBrigham and Women's Hospital and Harvard Medical School, Boston, Department of Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts.
Michael H ChoBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Kathleen VanniBrigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0003-0839-9661
Emily KowalskiBrigham and Women's Hospital, Boston, Massachusetts.
Grace QianBrigham and Women's Hospital, Boston, Massachusetts.
Katarina BadeBrigham and Women's Hospital, Boston, Massachusetts.
Alene SaavedraBrigham and Women's Hospital, Boston, Massachusetts.
Yumeko KawanoBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-2423-5982
Michael DiIorioBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Taylor WolfgangBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Edy Y KimBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Paul F DellaripaBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-0237-739X
Michael E WeinblattBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Nancy ShadickBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-3953-845X
Tracy J DoyleBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Jeffrey A SparksBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-5556-4618

Funding

VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYticsP30AR072577 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Daniel Hal Solomon · 2017 to 2026
$9.8M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung DiseaseR01AR077607 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SPARKS, JEFFREY ANDREW · 2021 to 2025
$3.7M
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4qR01HL147148 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H., SILVERMAN, EDWIN K · 2019 to 2022
$3.5M
Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular PhenotypesR01HL155522 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Jeffrey Andrew Sparks, George R Washko · 2022 to 2026
$3.5M
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in SmokersR01HL149861 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H., DIAZ, ALEJANDRO · 2020 to 2023
$3.2M
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic DiseasesR01AR080659 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Jeffrey Andrew Sparks · 2023 to 2026
$2.9M
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPDR01HL153248 · NHLBI · UNIVERSITY OF VIRGINIA · PI CHO, MICHAEL H., MANICHAIKUL, ANI WANG · 2021 to 2024
$2.8M
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_SupplementK08HL159318 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Matthew R Moll · 2022 to 2026
$918k
Clinical and Molecular Characteristics of Rheumatoid Arthritis-associated ILDK23HL119558 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DOYLE, TRACY JENNIFER · 2015 to 2018
$763k
Molecular and Genetic Characteristics of Progressive Rheumatoid Arthritis-associated Interstitial Lung DiseaseR03HL148484 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DOYLE, TRACY JENNIFER · 2019 to 2020
$134k
Llura Gund AwardNHLBI NIH HHS K08 HL159318NHLBI NIH HHS K23 HL119558NHLBI NIH HHS K23-HL-119558NHLBI NIH HHS R01 HL147148NHLBI NIH HHS R01-HL-147148NHLBI NIH HHS R01 HL149861NHLBI NIH HHS R01-HL-149861NHLBI NIH HHS R01 HL153248NHLBI NIH HHS R01-HL-153248NHLBI NIH HHS R01 HL155522NHLBI NIH HHS R03 HL148484NHLBI NIH HHS R03-HL-148484NIAMS NIH HHS P30 AR070253NIAMS NIH HHS P30-AR-070253NIAMS NIH HHS P30 AR072577NIAMS NIH HHS P30-AR-072577NIAMS NIH HHS R01 AR077607NIAMS NIH HHS R01-AR-077607NIAMS NIH HHS R01 AR080659R. Bruce and Joan M. Mickey Research Scholar FundRheumatology Research FoundationSociété Française de Rhumatologie
6 · The paper itself

Abstract

objectiveRheumatoid arthritis-associated interstitial lung disease (RA-ILD) includes multiple subtypes with varying histopathology, prognosis, and potential treatments. Limited research has investigated risk factors for different RA-ILD subtypes. Therefore, we examined demographic, serologic, and lifestyle associations with RA-ILD subtypes.

methodsWe systematically identified RA-ILD cases and RA controls without ILD (RA-noILD) in the Brigham RA Sequential Study and Mass General Brigham Biobank RA cohort. We determined RA-ILD subtype (usual interstitial pneumonia [UIP], nonspecific interstitial pneumonia [NSIP], and other/indeterminate) through chest high-resolution computed tomography imaging pattern. We investigated associations of demographic, lifestyle, and serologic factors with major RA-ILD subtypes using multivariable logistic regression.

resultsAmong 3,328 patients with RA, we identified 208 RA-ILD cases and 547 RA-noILD controls. RA-UIP was associated with older age (odds ratio [OR] 1.03 per year, 95% confidence interval [95% CI] 1.01-1.05), male sex (OR 2.15, 95% CI 1.33-3.48), and seropositivity (OR 2.08, 95% CI 1.24-3.48), whereas RA-NSIP was significantly associated only with seropositive status (OR 3.21, 95% CI 1.36-7.56). Nonfibrotic ILDs were significantly associated with smoking (OR 2.81, 95% CI 1.52-5.21). Having three RA-ILD risk factors (male, seropositive, smoking) had an OR of 6.89 (95% CI 2.41-19.7) for RA-UIP compared with having no RA-ILD risk factors.

conclusionOlder age, seropositivity, and male sex were strongly associated with RA-UIP, whereas RA-related autoantibodies were associated with RA-NSIP. These findings suggest RA-ILD sex differences may be driven by RA-UIP and emphasize the importance of further studies to clarify RA-ILD heterogeneity and optimize screening and treatment approaches.

Indexed as

Arthritis, RheumatoidLung Diseases, InterstitialSmokingAdultAgedAge FactorsCase-Control StudiesFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsSex Factors

Identifiers

PMID39257341
PMCPMC11772125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.